|
Can’t access the links? Add “lnks.gd” to the allowlist of your content blocking software. |
|
|
The Washington State Health Care Authority is seeking applications from interested physicians to fill an opening on the Washington State Pharmacy & Therapeutics (P&T) Committee beginning on February 1, 2025.
The purpose of the committee is to evaluate the available evidence of the relative safety, efficacy, and effectiveness of prescription drugs within a class of prescription drugs and make recommendations to the appointing authority for its deliberation in the development of the Washington preferred drug list established in RCW 70.14.050. The P&T Committee also serves as the Apple Health (Medicaid) Drug Utilization Review (DUR) Board. The DUR Board does a similar evaluation of drug classes for the Apple Health preferred drug list.
The initial term of appointment is 3 years. Members of the committee are expected to attend six full day virtual meetings a year, with a few hours of reading to prepare for the meeting. Members of the committee will be compensated for attendance at meetings in accordance with a personal services contract executed after appointment to the committee.
|
|
|
|